Balyasny Asset Management LLC Bluebird Bio, Inc. Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020
BUY
$34.44 - $43.75 $7.99 Million - $10.2 Million
232,000 Added 1288.89%
250,000 $13.5 Million
Q4 2018

Feb 14, 2019
SELL
$59.1 - $93.26 $6.93 Million - $10.9 Million
-117,200 Reduced 86.69%
18,000 $1.79 Million
Q2 2018

Aug 14, 2018
BUY
$99.64 - $127.59 $13.5 Million - $17.3 Million
135,200 New
135,200 $21.2 Million

Others Institutions Holding BLUE

# of Institutions
150
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $765M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email